Bespak are a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...

Expands Phillips Medisize’s inhalation drug delivery capabilities.

"The acquisition of Vectura reflects our commitment to advancing industry-leading medical capabilities for our customers," said Joe Nelligan, CEO, Molex, which acquired Phillips Medisize in 2016.

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...

Tomarket introduces a daily combo feature that offers fun puzzles and rewards such as tokens, rare items, and exclusive perks, accessible via Telegram and powered by the TON blockchain.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

Read more. FDA clears investigational new drug application for inhaled nicotine replacement therapy The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN ...